研究报告

基于网络药理学及分子对接探讨白桦茸防治阿尔兹海默病的潜在作用机制

  • 符丹丹 ,
  • 邵鑫源 ,
  • 张琦 ,
  • 张迪 ,
  • 彭心暖 ,
  • 刘燕山 ,
  • 孙建瑞 ,
  • 宫强
展开
  • 1(河南科技大学 食品与生物工程学院,河南 洛阳,471023)
    2(河南省食品微生物工程技术研究中心, 河南 洛阳,471023)
    3(微生物资源开发与利用河南科技大学重点实验室, 河南 洛阳, 471023)
第一作者: 博士,讲师 (通信作者, E-mail:fudandanly@126.com)

收稿日期: 2025-01-10

  修回日期: 2025-03-17

  网络出版日期: 2025-08-01

基金资助

河南省自然科学基金项目(242300420145)河南省科技攻关项目(232102110134)

Potential mechanism of chaga mushroom in treatment of Alzheimer’s disease based on network pharmacology and molecular docking

  • FU Dandan ,
  • SHAO Xinyuan ,
  • ZHANG Qi ,
  • ZHANG Di ,
  • PENG Xinnuan ,
  • LIU Yanshan ,
  • SUN Jianrui ,
  • GONG Qiang
Expand
  • 1(School of Food and Biological Engineering, Henan University of Science and Technology, Luoyang 471023, China)
    2(Henan Food Microbiology Engineering and Technology Research Center, Luoyang 471023, China)
    3(University Key Laboratory of Microbiology Resources Development and Utilization of Henan University of Science and Technology, Luoyang 471023, China)

Received date: 2025-01-10

  Revised date: 2025-03-17

  Online published: 2025-08-01

摘要

该研究利用网络药理学和分子对接技术,进行了白桦茸的活性成分、关键靶点和信号通路分析,以明确白桦茸防治阿尔茨海默病(Alzheimer’s disease,AD)的潜在作用机制。从TCMSP等数据库和文献获得白桦茸的活性成分以及作用靶点,通过GeneCards等数据库获得疾病的靶点,得到白桦茸和阿尔茨海默病的共同作用靶点,通过String数据库构建共同靶点的蛋白质互作(protein-protein interaction,PPI)网络图,运用Cytoscape软件构建“活性成分-靶点”网络图,并通过DAVID和Metascape数据库进行GO富集和KEGG通路富集分析,再通过Autodock软件进行分子对接模拟。最终筛选得9种活性成分,阿尔茨海默病筛选到3 397个靶点,由PPI筛选得到MMP3、IL6、AKT1、IL10、TNF、MAPK1和HSP90AB1等关键靶点20个,由KEGG通路分析可知桦褐孔菌通过脂质和动脉粥样硬化通路、乙肝、人巨细胞病毒感染、白介素-17及阿尔茨海默病等信号通路发挥抗AD作用。由GO富集分析发现其与RNA聚合酶Ⅱ转录因子复合物、质膜的组成部分、RNA聚合酶Ⅱ启动子的pri-miRNA正调节转录通路等相关。将20个关键靶点与白桦茸活性成分分子对接,验证均能稳定结合,预测槲皮素等化学成分在缓解阿尔茨海默病中发挥重要作用。白桦茸通过多成分、多靶点、多通路干预脂质和动脉粥样硬化及阿尔茨海默病等多个信号通路,从而发挥白桦茸抗阿尔茨海默病的功能,为药食同源保健食品的开发提供理论依据。

本文引用格式

符丹丹 , 邵鑫源 , 张琦 , 张迪 , 彭心暖 , 刘燕山 , 孙建瑞 , 宫强 . 基于网络药理学及分子对接探讨白桦茸防治阿尔兹海默病的潜在作用机制[J]. 食品与发酵工业, 2025 , 51(14) : 228 -235 . DOI: 10.13995/j.cnki.11-1802/ts.042100

Abstract

To investigate the potential mechanisms of Chaga mushroom in the treatment of Alzheimer’s disease (AD), network pharmacology and molecular docking techniques were used to predict the active components, key targets, and signalling pathways.The active components and target genes of Inonotus obliquus were obtained from databases such as TCMSP and literature.The disease targets of AD were acquired through databases such as GeneCards to identify the common targets of Inonotus obliquus and Alzheimer’s disease.The protein-protein interaction (PPI) network diagram of common targets was constructed using the String database, and the interaction network of “active components-key targets” was constructed by Cytoscape software.GO and KEGG enrichment analyses were performed by DAVID and Metascape databases.Molecular docking simulations were conducted using Autodock software.Finally, 9 active components and 3 397 targets of Alzheimer’s disease were screened out.Twenty key targets were obtained by PPI, such as MMP3, IL6, AKT1, IL10, TNF, MAPK1, HSP90AB1, and so on.KEGG pathway analysis showed that Inonotus obliquus played an anti-AD role through the signalling pathways of lipid and atherosclerosis, hepatitis B, human cytomegalovirus infection, interleukin-17, Alzheimer’s disease, and so on.GO enrichment analysis showed that it was related to RNA polymeraseⅡtranscription factor complex, an integral component of the plasma membrane, positive regulation of pri-miRNA transcription from RNA polymeraseⅡpromoter, and so on.20 key targets were docked with their corresponding active components to verify that they could bind stably, which predicted that quercetin played an important role in alleviating Alzheimer’s disease.Chaga mushroom could interfere with multiple signalling pathways, such as lipid and atherosclerosis, as well as through multiple components and targets, providing theoretical support for the development of medicine and food homologous health foods.

参考文献

[1] 张赫, 郑焱.β淀粉样蛋白级联假说相关的阿尔茨海默病发病机制及防治策略研究进展[J].中国医学科学院学报, 2019, 41(5):702-708.
ZHANG H, ZHENG Y.β amyloid hypothesis in Alzheimer’s disease:Pathogenesis, prevention and management[J].Acta Academiae Medicinae Sinicae, 2019, 41(5):702-708.
[2] LONG S, BENOIST C, WEIDNER W.World Alzheimer report 2023.Reducing dementia risk:never too early, never too late[R].London:Alzheimer’s Disease International, 2023.
[3] 张晨曦, 董承瑜, 胡鑫,等.中药治疗阿尔茨海默病分子作用机制的研究进展[J].中草药, 2022, 53(13):4132-4145.
ZHANG C X, DONG C Y, HU X, et al.Research progress on molecular mechanism of traditional Chinese medicine in treatment of Alzheimer’s disease[J].Chinese Traditional and Herbal Drugs, 2022, 53(13):4132-4145.
[4] 储超扬, 肖彪, 单江晖, 等.酶抑制剂及其构效优化在阿尔茨海默病中的应用[J].生物化学与生物物理进展, 2024, 51(7):1510-1529.
CHU C Y, XIAO B, SHAN J H, et al.Application study of enzyme inhibitors and their conformational optimization in the treatment of Alzheimer’s disease[J].Progress in Biochemistry and Biophysics, 2024, 51(7):1510-1529.
[5] GU X R, ZHOU J Y, ZHOU Y Y, et al.Huanglian Jiedu Decoction remodels the periphery microenvironment to inhibit Alzheimer’s disease progression based on the “brain-gut” axis through multiple integrated omics[J].Alzheimer’s Research & Therapy, 2021, 13(1):44.
[6] 蔡可珍, 郑琴, 朱徐东, 等.基于UPLC-Q-TOF-MS结合网络药理学与实验验证探讨四君子汤治疗阿尔茨海默病的作用机制[J].中国中药杂志, 2023, 48(6):1620-1631.
CAI K Z, ZHENG Q, ZHU X D et al.Mechanism of Sijunzi Decoction in treatment of Alzheimer’s disease based on UPLC-Q-TOF-MS, network pharmacology, and experimental verification[J].China Journal of Chinese Materia Medica, 2023, 48(6):1620-1631.
[7] FAN Y T, WANG A M, LIU Z Q, et al.Integrated spatial metabolomics and network pharmacology to explore the pharmacodynamic substances and mechanism of Radix ginseng-Schisandra chinensis Herb Couple on Alzheimer’s disease[J].Analytical and Bioanalytical Chemistry, 2024, 416 (19):4275-4288.
[8] PENG Y T, ZHOU C J.Network pharmacology and molecular docking identify the potential mechanism and therapeutic role of Scutellaria baicalensis in Alzheimer’s disease[J].Drug Design, Development and Therapy, 2024, 18:1199-1219.
[9] LV F, SUN M, QIN C M, et al.Study of the multitarget mechanism of Astragalus(HUANGQI) in the treatment of Alzheimer′s disease based on network pharmacology and molecular docking technology[J].Pharmaceutical Biology, 2024, 62(1):634-647.
[10] KUANG F, XIANG T.Molecular mechanism of Acanthopanax senticosus in the treatment of Alzheimer′s disease based on network pharmacology and molecular docking[J].Molecular Diversity, 2023, 27(6):2849-2865.
[11] 吴超, 袁鑫, 郑红.基于APP/BACE1/Aβ信号通路的人参皂苷Rg1对AD树鼩模型的神经保护作用[J].中国医院药学杂志, 2024, 44(1):18-22;34.
WU C, YUAN X, ZHENG H.Neuroprotective effect of ginsenoside Rg1 based on the APP/BACE1/Aβ signaling pathway on Alzheimer’s tree shrew model[J].Chinese Journal of Hospital Pharmacy, 2024, 44(1):18-22;34.
[12] SHEN W P, WU J M, SHI L Y, et al.Explore the mechanisms of triterpenoids from Ganoderma lucidum in the protection against Alzheimer’s disease via microbiota-gut-brain axis with the aid of network pharmacology[J].Fitoterapia, 2024,178:106150.
[13] 张旭, 赵芬琴, 韩光, 等.桦褐孔菌的化学成分及抗炎活性[J].天然产物研究与开发, 2010, 22(3):433-436.
ZHANG X, ZHAO F Q, HAN G, et al.Chemical constituents and anti-inflammatory activities of Inonotus obliquus[J].Natural Product Research and Development, 2010, 22(3):433-436.
[14] HU Y, SHENG Y, YU M, et al.Antioxidant activity of Inonotus obliquus polysaccharide and its amelioration for chronic pancreatitis in mice[J].International Journal of Biological Macromolecules, 2016, 87:348-356.
[15] 刘畅, 崔敬爱, 王思霁, 等.桦褐孔菌多糖对糖尿病肾病小鼠肾脏的保护作用[J].食品工业科技, 2021, 42(2):321-325.
LIU C, CUI J A, WANG S J, et al.Protective effect of Inonotus obliquus polysaccharides on kidneys of diabetic kidney disease mice[J].Science and Technology of Food Industry, 2021, 42(2):321-325.
[16] 程欢欢, 宋辉, 刘博男, 等.基于网络药理学及分子对接探讨桦褐孔菌三萜类成分抗胃癌作用机制[J].天然产物研究与开发, 2021, 33(8):1391-1400.
CHENG H H, SONG H, LIU B N, et al.Study on the mechanism of triterpenoids from Inonotus obliquus against gastric cancer based on network pharmacology and molecular docking[J].Natural Product Research and Development, 2021, 33(8):1391-1400.
[17] 武建平, 李文兰, 曲中原, 等.基于网络药理学探讨桦褐孔菌降血糖功效成分及作用机制[J].食品工业科技, 2021, 42(22):18-29.
WU J P, LI W L, QYU Z Y, et al.Action mechanism of Inonotus obliquus in the treatment of diabetes and the material basis of pharmacodynamics based on network pharmacology[J].Science and Technology of Food Industry, 2021, 42(22):18-29.
[18] LU Y P, JIA Y N, XUE Z H, et al.Recent developments in Inonotus obliquus (chaga mushroom) polysaccharides:Isolation, structural characteristics, biological activities and application[J].Polymers, 2021, 13(9):1441-1441.
[19] 陶丽清, 张衡.三萜类化合物在阿尔茨海默病防治中的研究进展[J].生命科学, 2024, 36(4):487-498.
TAO L Q, ZHANG H.Research progress of triterpenoids in the prevention and treatment of Alzheimer’s disease[J].Chinese Bulletin of Life Sciences, 2024, 36(4):487-498.
[20] 赵丽洁, 赵慧, 郭丹, 等.孕酮和骨化三醇通过miR-590-5p靶向RelA调控子宫内膜癌细胞Ishikawa的细胞因子分泌[J].中国免疫学杂志, 2022, 38(11):1343-1348.
ZHAO L J, ZHAO H, GUO D, et al.Progesterone and calcitriol use miR-590-5p to target RelA to regulate cytokine secretion in endometrial cancer cells Ishikawa[J].Chinese Journal of Immunology, 2022, 38(11):1343-1348.
[21] 陈宣世, 刘梦文, 沈静, 等.基于 HPLC 指纹图谱及网络药理学探讨黑桑葚防治阿尔兹海默病潜在机制[J].食品与发酵工业, 2024, 50(13):270-278.
CHEN X S, LIU M W, SHEN J, et al.The mechanism of black mulberry reatment for AD was studied based on HPLC fingerprint and network pharmacology[J].Food and Fermentation Industries, 2024, 50(13):270-278.
[22] MIZUNO N, IWATA T, OHSAWA R, et al.Optineurin regulates osteoblastogenesis through STAT1[J].Biochemical and Biophysical Research Communications, 2020, 525(4):889-894.
[23] 殷春燕, 董占军, 陈江魁.基于网络药理学和分子对接技术研究花生红衣多酚抗动脉粥样硬化的作用机制[J].食品与发酵工业, 2023, 49(20):242-249.
YIN C Y, DONG Z J, CHEN J K.Study on anti-atherosclerosis mechanism of action of peanut skin polyphenols based on network pharmacology and molecular docking[J].Food and Fermentation Industries, 2023, 49(20):242-249.
[24] WANG D M, LI S Q, WU W L, et al.Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer’s disease[J].Neurochemical Research, 2014, 39(8):1533-1543.
[25] 成云芳, 孙邈, 戴轶伟, 等.山奈酚对阿尔茨海默病大鼠学习记忆功能及海马组织中极性蛋白Par3、Par6和aPKC表达的影响[J].中国老年学杂志, 2024, 44(18):4480-4484.
CHENG Y F, SUN M, DAI Y W, et al.Effects of kaempferol on learning and memory function and the expressions of polar protein Par3, Par6 and aPKC in hippocampus of Alzheimer’s disease rats[J].Chinese Journal of Gerontology, 2024, 44(18):4480-4484.
[26] AYAZ M,JUNAID M,ULLAH F, et al.Anti-alzheimer’s studies on β-sitosterol isolated from Polygonum hydropiper L[J].Frontiers in Pharmacology, 2017, 8:697.
[27] CHEN F,SUN Z Q,ZHU X G,et al.Astilbin inhibits high glucose-induced autophagy and apoptosis through the PI3K/Akt pathway in human proximal tubular epithelial cells[J].Biomedicine & Pharmacotherapy, 2018, 106:1175-1181.
[28] JAYARAMAN A, REYNOLDS R.Diverse pathways to neuronal necroptosis in Alzheimer’s disease[J].The European Journal of Neuroscience, 2022, 56(9):5428-5441.
文章导航

/

〈 〉